|Titre :||"You don’t have to squirrel away in a staircase": Patient motivations for attending a novel supervised drug consumption service in acute care (2021)|
|Auteurs :||B. KOSTENIUK ; G. SALVALAGGIO ; R. MCNEIL ; H. L. BROOKS ; K. DONG ; S. TWAN ; J. BROUWER ; E. HYSHKA|
|Type de document :||Article : Périodique|
|Dans :||International Journal of Drug Policy (Vol.96, October 2021)|
|Article en page(s) :||art. 103275|
|Discipline :||TRA (Traitement et prise en charge / Treatment and care)|
Thésaurus TOXIBASEETUDE QUALITATIVE ; USAGER ; REDUCTION DES RISQUES ET DES DOMMAGES ; SALLE DE CONSOMMATION A MOINDRE RISQUE ; PRODUIT ILLICITE ; ETHNOGRAPHIE ; HOPITAL ; ACCES AUX SOINS ; SECURITE
Background: Acute care hospitals have been described as a high risk environment for people who use drugs (PWUD). Formal and informal bans on drug use can lead patients to conceal their use and consume under unsafe circumstances. Provision of hospital-based supervised consumption services (SCS) could help reduce drug-related harms and improve patient care. However, no peer-reviewed research documents patient experiences with attending SCS in this setting. To address this gap, the present study examines key factors that shape patients' decisions to attend or not attend a novel SCS embedded within a large, urban acute care hospital in Western Canada.
Methods: We adopted a focused ethnographic design and conducted 28 semi-structured interviews with SCS-eligible patients. We examined participant accounts thematically, and Rhodes' "Risk Environment" framework helped guide our analysis.
Results: Most participants perceived the SCS as a safer environment that made it possible to reduce drug-related risks and avoid using in unsafe areas of the hospital where they could be caught by staff, security, or police. However, some participants did not trust that the SCS would provide adequate protection from criminalization, which motivated them to avoid the site. Several participants also worried about the potential for unwanted changes to their patient care following SCS use. Physical site and policy limitations, such as eligibility requirements and a lack of infrastructure to support supervised inhalation, were additional reasons for not attending the SCS.
Conclusion: PWUD in this study attended the hospital-based SCS in an attempt to reduce risks associated with their hospital stay. However, we note a number of access barriers that should be addressed to ensure optimal uptake. Wider provision of SCS in acute care requires both changes to the hospital environment and broader drug policy reform.
• Patients attend hospital-based supervised consumption services (SCS) to reduce risks associated with unsanctioned drug use during their hospital admission.
• Threat of criminalization is a persistent barrier to SCS access in hospital.
• SCS policy is needed to support drug inhalation and patients' accompaniment by guests.
• Maximizing SCS uptake will be challenging without broader drug policy reform.
|Domaine :||Drogues illicites / Illicit drugs|
|Affiliation :||School of Public Health, University of Alberta, Edmonton, AL, Canada|